Methylphenidate has been the first-line treatment for children and adolescents with attention-deficit hyperactivity disorder for more than half a century. Yet, after numerous systematic reviews, three applications to get methylphenidate on the List of Essential Medicines and three rejections by the World Health Organization, the questions remain: does it work, and how do we know?